Since the outbreak of COVID-19, new scientific analyses and insider accounts have revealed major vulnerabilities in how the U.S. oversees high-risk biological research. Join us as Dr. Robert Redfield, Dr. Richard Ebright, and Dr. Alina Chan explore the scientific and national security implications of gain-of-function research, highlight weaknesses in current oversight, and discuss realistic reforms to strengthen America’s biosafety posture. |